Posted in: Ingredient Buyer Guides
Quick answer: Compare sodium hyaluronate molecular weight data only after aligning the reported parameter, units and test method. Review viscosity under defined conditions, then evaluate a traceable sample in the intended formula. A label such as “low molecular weight” or one viscosity number is not enough to establish that two materials are interchangeable.
This guide helps supplement formulators, QA reviewers and procurement teams turn supplier data into a comparison worksheet. For current product documentation and commercial inquiries, use the Sodium Hyaluronate product page. The questions below do not describe a confirmed range of GNB grades or establish suitability for a particular market.

Sodium Hyaluronate Molecular Weight: Define Identity, Method, and Assay
Sodium hyaluronate is the sodium salt of hyaluronic acid. Identity tells a buyer what material is being evaluated; molecular-weight information describes a different attribute from assay. A higher assay result does not, by itself, establish a higher molecular weight or better behavior in a capsule, powder blend or liquid formulation.
Record the exact ingredient name, material composition and source declaration for each offer. Ask whether the assay reports sodium hyaluronate or hyaluronic-acid content and whether it is expressed on a dry or as-is basis. Keep that information beside the molecular-weight data, rather than combining both into an undefined “purity” claim.
Sodium Hyaluronate Molecular Weight Ranges Need Clear Definitions
For each sodium hyaluronate molecular weight claim, do not assume that suppliers use “low,” “medium” or “high” for identical ranges. Ask each supplier to state the numerical range, unit, reported average and method. If an offer only gives a descriptive grade name, mark the comparison as incomplete.
An average value and a distribution profile answer different questions. Ask which parameter is reported, whether the document provides a range or a single value, and whether the result is measured directly or calculated from another measurement. If a viscosity-based calculation is used, request the stated calculation approach and conditions. QA should decide whether results generated by different methods can support the same acceptance decision.
Normalize units before reviewing offers, but do not treat a unit conversion as proof that analytical methods are equivalent. Likewise, a typical brochure value is not automatically a result for the sample or proposed commercial lot.
Do not compare viscosity numbers without test conditions
Intrinsic viscosity and solution viscosity are different measurements. Record which one the document reports and its units. For a solution-viscosity result, request the concentration, solvent or medium, temperature, instrument or measurement method, and relevant measurement settings. Record pH and hydration time where they form part of the procedure.
A supplier result obtained in one test solution may not predict texture or processing behavior in a finished formula containing minerals, acids, flavors or other ingredients. Use the document to understand what was tested, then define a development trial that reflects the intended manufacturing process.
Sodium Hyaluronate Molecular Weight Comparison Worksheet
This sodium hyaluronate molecular weight comparison worksheet helps you record one copy of the table for each offer. Keep missing information visible and assign it to the supplier, formulation team or QA reviewer before making a substitution decision.
| Field | What to record for each offer | Question before comparison |
|---|---|---|
| Identity and composition | Exact ingredient name, declared composition and source statement | Are both documents describing the same material form? |
| Assay | Analyte, result, method and dry/as-is basis | Are the results expressed on a comparable basis? |
| Molecular weight | Range, units, type of average or distribution, method | Is the parameter defined, rather than just a grade label? |
| Viscosity | Measurement type, units and full test conditions | Can the two reported values be compared meaningfully? |
| Evidence status | Typical value, specification limit or lot result; document version | Does this information apply to the offered sample and lot? |
| Sample trial | Sample lot, formula, process and observed results | Was the sample evaluated under the buyer’s intended conditions? |
| Commercial transfer | Proposed bulk lot, specification reference and change-notification terms | What must be reconfirmed before commercial supply? |
Connect the comparison to the dosage form
For capsules and tablets, ask the development team which handling, blend-uniformity and processing properties require evaluation. Molecular-weight information alone does not establish filling behavior or compression performance. For sachets and dry blends intended for reconstitution, assess dispersion, visible lumps, hydration time and the sensory properties relevant to the concept.
For a liquid concept, define the intended concentration, addition sequence, mixing conditions, pH and temperature before testing. Observe the result after a defined hydration period. Assess compatibility and stability in the actual formula and packaging; do not infer market authorization or finished-product shelf life from a raw-material COA.
There is no universal best molecular-weight grade for every project. Choose the evaluation criteria from the intended use and process, then ask whether the offered material meets them. Where a numerical limit has not been justified, keep it open for formulation and QA review.
From a development sample to a bulk order
Identify the sample lot and retain its specification and COA alongside the trial record. Before a bulk order, compare the proposed lot against the approved requirements and resolve differences in method, reporting basis or document version. If a sample is not representative of the proposed supply, agree what further evidence is needed before approval. Carry the accepted sodium hyaluronate molecular weight range into lot review and confirm the offered lot uses the agreed reporting method.
Review relevant impurity, heavy-metal and microbiological requirements with QA, and request source and market-specific documentation as appropriate. Packaging, moisture protection, storage instructions, retest or expiry information, MOQ and lead time must be confirmed for the offered material and order. This guide supplies no universal limits or fixed commercial terms.
For the distinction between an agreed acceptance document and a lot report, see COA vs Specification. The broader quality-control overview provides company-level context; it does not replace product-specific evidence.
What to send in a technical RFQ
Include the intended dosage form, destination market, ingredient identity, requested molecular-weight information, assay basis, viscosity test conditions if already defined, sample requirement and estimated purchase quantity. Separate mandatory requirements from preferences and unresolved questions. Ask for the current specification and the documentation applicable to the proposed sample or lot.
Send the completed comparison fields through Request a Quote and identify any measurements that still need clarification. Current availability, documentation, packaging and timing require confirmation from the sales team.
Frequently asked questions
Does a higher sodium hyaluronate assay mean a higher molecular weight?
No. Assay and molecular-weight information describe different attributes. Review the analyte and assay basis separately from the molecular-weight parameter and method.
Can I compare two low-molecular-weight sodium hyaluronate offers by name?
No. Obtain the defined range, units, type of average and test method for each offer. A shared descriptive grade name does not demonstrate equivalent materials.
Does matching solution viscosity prove two grades are interchangeable?
No. First align the measurement procedure and conditions. Then review identity, assay, molecular-weight data and the sample’s performance in the intended formula before deciding whether substitution is appropriate.
Does GNB’s public COA establish every available molecular-weight grade?
No. A public lot document should be read within its own scope. Ask GNB to confirm the current offered material, molecular-weight documentation and sample-to-lot relationship for your project.
Reading and evidence scope
The GNB Sodium Hyaluronate listing provides the public product context and a linked batch document. This article does not extrapolate that document into a catalogue-wide specification. For scientific background on hyaluronan identity and properties, see Fraser, Laurent and Laurent, Hyaluronan: its nature, distribution, functions and turnover, Journal of Internal Medicine (1997). Product-specific suitability and destination-market requirements remain matters for the responsible technical and regulatory reviewers.





